Skip to main content
OpenTrials
Completed

NCT Number: NCT00199784

Hemodynamic Measurements During Cesarean Section With Spinal Anesthesia

The purpose of this study is to determine the effect of low dose versus standard dose spinal anesthesia with and without intravenous phenylephrine-infusion on blood pressure, cardiac output and systemic vascular resistance.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–50 year

Sex eligibility

Female

Study type

Interventional

Phase

Phase 4

Primary location

Rikshospitalet-Radiumhospitalet HF

Oslo, 0027, Norway

About this study

Hypotension during cesarean section with spinal anesthesia is common. We compare low dose versus standard dose spinal anesthesia with and without intravenous phenylephrine-infusion.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Healthy pregnant women for elective cesarean section

Exclusion criteria

  • Shorter than 160 or taller than 180 cm
  • Pre-pregnant body mass index (BMI) over 32

Treatment and study plan

Phenylephrine

Drug

Primary outcomes

  1. Differences in cardiac output

  2. Blood pressure

  3. Systemic vascular resistance

Secondary outcomes

  1. Nausea

  2. Fatigue

  3. Cardiovascular instability due to overdosing spinal anesthesia for cesarean section (CS)

Sponsors and collaborators

Lead sponsor

Oslo University Hospital

Other

Registry information

Important dates

Study start
2005
Study completion
2007
First posted
Sep 20, 2005
Registry last updated
Jul 6, 2011

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.